Stocker, Andreas (Biomeva GmbH 201305 Director of Business Development) |
Business Development Manager / Strategy Manager |
Asahi Glass (AGC) (Group) |
Germany |
Stoekli, Markus (Novartis 201606 Novartis Instituts for BioMedical Research) |
Researcher (industry) |
Waters (Group) |
United States (USA) |
Stoffel, Boris (Miltenyi Biotec 201301 CEO before Memorec Stoffel) |
Managing Director |
Miltenyi Biotec (Group) |
Germany |
Stoffel, Ruedi (Roche 201210 Head of Custom Biotech) |
n. a. |
Roche (Group) |
Germany |
Stoffel, Stefan (Lonza 201903– COO of Lonza Pharma Biotech & Nutrition segment joined 1991) |
President/Director/Head Business Group/Unit/Division |
Lonza (Group) |
Switzerland |
Stoffelen, Richard (Centogene 201805 CFO) |
Chief Financial Officer (CFO) |
Centogene (Group) |
Germany |
Stojanov, Tomas (Genea Biomdex 201505 CEO) |
Chief Executive Officer (CEO) |
Genea Biomedx (AU) |
Australia |
Stolberg, Nikolaus Graf (Medac 201703 Managing Director) |
Managing Director |
Medac Gesellschaft für klinische Spezialpräparate mbH |
Germany |
Stoll, Dwight (Gastavus Adolphus College, Minnesota 201704 Associate Professor) |
Professor |
|
|
Stoll, Norbert (Analytical Instrument GmbH 201103 Managing Director) |
Managing Director |
Analytical Instrument GmbH (AIG) |
Germany |
Stolle, Katja (Messe München 201202– interim Exhibition Director Analytica) |
Product Manager (personnel) |
Messe München GmbH |
Germany |
Stoller, Anne-Kathrin (Bachem 201203 VP Marketing + Sales) |
Sales Manager / Marketing Manager |
Bachem (Group) |
Switzerland |
Stone, Adam (Perceptive Advisors 202003 Chief Investment Officer) |
Investment Manager |
Perceptive Advisors LLC |
United States (USA) |
Stonehouse, Jon P. (BioCryst 200902 CEO before Merck KGaA) |
Chief Executive Officer (CEO) |
BioCryst Pharmaceuticals Inc. (Nasdaq: BCRX) |
United States (USA) |
Stoops, Sooike (VIB 201704 Expert Press + Public Communications) |
Public Relations Manager / Investor Relations Manager |
VIB (Flanders Interuniversity Institute for Biotechnology / Vlaams Instituut voor Biotechnologie) |
Belgium |
Storck, Thorsten (Gentana 200407–) |
n. a. |
Gentana GmbH |
Germany |
Storm, Detlef (Becton Dickinson 201304 Marketing Manager Central Europe at BD Diagnostics Heidelberg) |
Sales Manager / Marketing Manager |
Becton, Dickinson (Group) |
Germany |
Stormorken, Pål O. (Yara 201702 Head of Application + Crop Management Systems) |
President/Director/Head Business Group/Unit/Division |
Yara (Group) |
Norway |
Stoten, Adam (Isis Innovation 200509) |
IP Manager |
University of Oxford |
United Kingdom (GB) |
Stout, Katja (Scius Communications 201808– before LifeSci London + Citigate Dewe Rogerson + Northbank Communications) |
Public Relations Manager / Investor Relations Manager |
Scius Communications (GB) |
United Kingdom (GB) |
Stragier, Patrick (Promethera 201512– VP Operations before Solvay + DSM Biologics + Genzyme + Lonza + MaSTherCell) |
Chief Operating Officer (COO) |
Promethera (Group) |
Belgium |
Strasser, Ralf (Dynamic Biosensors 202209 COO + Co-Founder) |
Chief Operating Officer (COO) |
Dynamic Biosensors (Group) |
Germany |
Strasser, Ruth |
n. a. |
University of Dresden |
Germany |
Stratford, Richard (OncoImmunity AS 201812 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
NEC (Group) |
Norway |
Stratmann, Martin (Max Planck 201406– President of Max Planck Society before Director at MPI für Eisenforschung) |
President/Director/Head Business Group/Unit/Division |
Max Planck Society for the Advancement of Science |
Germany |
Stratton, Kim (Centogene 202202– CEO before Orphazyme + Shire Pharmaceuticals + Novartis) |
Chief Executive Officer (CEO) |
Centogene (Group) |
Netherlands |
Stratton, Tim (Thermo Fisher 201506 Manager Library Technologies) |
Product Manager (personnel) |
Thermo Fisher (Group) |
United States (USA) |
Straubinger, Helmut J. (JenaValve 200709 CEO) |
Chief Executive Officer (CEO) |
JenaValve Technology GmbH |
Germany |
Straus, Joseph |
n. a. |
Max Planck Society for the Advancement of Science |
Germany |
Streibel, Lennart (Centogene 202202 Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Centogene (Group) |
Netherlands |
Streimelweger, Thomas (red-strars.com data 201908 CEO) |
Chief Executive Officer (CEO) |
red-stars.com data AG |
Austria |
Strek, Harry (Bayer 201411 Head of Bayer CropScience Weed Resistance Competence Center Ffm) |
Research & Development Manager |
Bayer (Group) |
Germany |
Striggow, Frank (Life Science Inkubator 201802 COO before KeyNeuroTek 200006– CEO) |
Chief Operating Officer (COO) |
Life Science Inkubator GmbH (LSI) |
Germany |
Strigini, Bruno (Novartis 201605–201801 Head Oncology Business Unit RETIRED 1/18 joined 2014 from Merck & Co) |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
Switzerland |
Strobl, Wolfram (Fresenius 201703 General Manager at Fresenius Medical Care Adsorber Tec GmbH) |
General Manager (management) |
Fresenius (Group) |
Germany |
Strode, Pamela (Fulcrum Therapeutics 201909– SVP Regulatory Affairs + Quality Assurance before Epizyme + BMS + BI |
Regulatory Affairs Manager |
Fulcrum Therapeutics Inc. (Nasdaq: FULC) |
United States (USA) |
Stroehlein, Guido (ChromaCon 201109 CEO) |
Chief Executive Officer (CEO) |
ChromaCon AG |
Switzerland |
Strohmeier, Fred (Agilent 201312– SVP + President Life Sciences + Dx business RETIRED 2015) |
President/Director/Head Business Group/Unit/Division |
Agilent (Group) |
United States (USA) |
Strohmenger, Rainer (Wellington Partners Venture Capital 201303 General Partner) |
General Partner (venture partner) |
Wellington Partners (Group) |
Germany |
Strom, Antje (KPMG 201608 Partner) |
consulting (economic) |
KPMG (Group) |
Germany |
Stropoli, Giovanni (Santhera 201502– Chief Commercial Officer before InterMune) |
Chief Commercial Officer (CCO) |
Santhera (Group) |
Switzerland |
Strub, Oliver (Santhera 201502– appointed General Counsel + Board Secretary) |
General Counsel / Chief Legal Officer (CLO) |
Santhera (Group) |
Switzerland |
Strube, Randy (InSphero 201401– Director of Global Marketing) |
Sales Manager / Marketing Manager |
InSphero (Group) |
Switzerland |
Struckmeyer, Thomas (EW Group 202012– CEO at BioCheck BV before IdentiGEN) |
Chief Executive Officer (CEO) |
EW Group (Erich Wesjohann) (Group) |
Netherlands |
Struhalla, Marc (c-LEcta GmbH 201105 Managing Director) |
Managing Director |
Kerry Group (Group) |
Germany |
Strüngmann, Andreas (Hexal founder + Biotech investor) |
Company Founder |
STRÜNGMANN Group (family Strüngmann) |
Germany |
Strüngmann, Thomas (Hexal founder + Biotech investor) |
Company Founder |
STRÜNGMANN Group (family Strüngmann) |
Germany |
Ströver, Rebekka (Leukocare 202103 Specialist Communications + Marketing) |
Public Relations Manager / Investor Relations Manager |
Leukocare (Group) |
Germany |
Stuart, Edward (HS Life Sciences 200901 CEO + founder before Neurimmune 200712 CEO before U3 Pharma AG before DeveloGen) |
Chief Executive Officer (CEO) |
HS LifeSciences (Group) |
Switzerland |
Stuart, Lynda (Gates Foundation 201909 Deputy Director Vaccines + Human Immunobiology, Discovery + Translational) |
n. a. |
GATES Group (family of Bill Gates) |
United States (USA) |
Stuart, Martin (Definiens 201201– EVP + General Manager North America + Asia Pacific before Aperio + Entropia) |
Regional manager |
AstraZeneca (Group) |
Germany |
Stubbers, Ron (InGeneron 201710 Head of Operations) |
Chief Operating Officer (COO) |
InGeneron (Group) |
Germany |
Stuber, Werner (BMD GmbH before BIO Mitteldeutschland 200810) |
Business Development Manager / Strategy Manager |
BMD Life Sciences GmbH |
Germany |
Stuge, Örn (Aleva Neurotherapeutics 201108 Chairmen Board of Directors) |
Board member, non-executive |
Aleva Neurotherapeutics S.A. |
Switzerland |
Stuhler, Gernot (Cherry Biolabs 202011 CEO + Founder + Prof at Univ Hospital Würzburg) |
Chief Executive Officer (CEO) |
Cherry Biolabs GmbH |
Germany |
Stukkens, Guy (Analis SA 201212 CEO) |
Chief Executive Officer (CEO) |
Analis S.A. |
Belgium |
Stumbaum, Mihaela (Univ Konstanz) |
Researcher (university / research institute) |
University of Constance (Universität Konstanz) |
Germany |
Sturge, Simon (Kymab 201905– CEO before Merck (DE) + Boehringer + OctoPlus + Vernalis + Celltech) |
Chief Executive Officer (CEO) |
Sanofi (Group) [since May 2011] |
United Kingdom (GB) |
Sturm, Andre (Vertama 202307 CEO + Founder) |
Managing Director |
Vertama GmbH (formerly UG) |
Germany |
Sturm, Stephan (Fresenius 202205 Supervisory Board Chair of Fresenius Medical Care Management + CEO of Fresenius) |
Chief Executive Officer (CEO) |
Fresenius (Group) |
|
Sturmhoefel, Knut (Novartis 201511 Head BD&L Ophthalmology + Respiratory) |
Business Development Manager / Strategy Manager |
Novartis (Group) |
Switzerland |
Stutz, Deborah (Sigma-Aldrich 201410 Director Biopharma Marketing) |
Sales Manager / Marketing Manager |
Merck (DE) (Group) |
United States (USA) |
Stübiger, Gerald (Medical Univ Vienna 201208 Institut für Gefäßbiologie + Thromboseforschung) |
Researcher (university / research institute) |
Medical University of Vienna (MedUni Wien) |
Austria |
Stübler, Hermann (Bayer 201606 Head of Weed Contral Research) |
Research & Development Manager |
Bayer (Group) |
Germany |
Stührk, Olaf (Commerzbank Berlin) |
n. a. |
Commerzbank (Group) |
Germany |
Stünkel, Klaus G. E. (ProBioGen 200708– VP BusDev Licensing before Bayer AG) |
Business Development Manager / Strategy Manager |
Minapharm (Group) |
Germany |
Stüttgen, Marcus (JnJ 201309 Director New Business Development at Janssen-Cilag GmbH) |
Business Development Manager / Strategy Manager |
Johnson & Johnson (JnJ) (Group) |
Germany |
Stäheli, Michael (PolyPeptide 202305 Head of IR + Corp Communications) |
Managing Director |
|
|
Stähler, Cord F. (febit 200401 CEO) |
Chief Executive Officer (CEO) |
febit (Group) |
Germany |
Stähler, Peer (febit biotech GmbH 200512) |
n. a. |
Hummingbird Diagnostics GmbH |
Germany |
Stöckemann, Klaus (Peppermint 200905 Managing Partner before 3i Deutschland before Schering + Asta Medica) |
Managing Partner (investment firm) |
Peppermint (Group) |
Germany |
Stöcker, Winfried (Euroimmun 201007 CEO) |
Chief Executive Officer (CEO) |
PerkinElmer (Group) |
Germany |
Stöckl, Lars (FyoniBio 202204 Managing Director) |
Managing Director |
Canton Biologics (Group) |
Germany |
Stöckl, Petra (Tirol (govt) 201105 Standortagentur Tirol Programme Manager Life Sciences) |
Business Development Manager / Strategy Manager |
Life Sciences Tirol (Cluster) |
Austria |
Stöhr, Thomas (A2M Pharma GmbH 201104 Managing Director) |
Managing Director |
A2M Pharma GmbH |
Germany |
Stölting, Michael (Nordrhein-Westfalen (govt) 202012 Management Board Member of NRW.Bank) |
Board member, executive |
Nordrhein-Westfalen (govt region) |
Germany |
Stölzle, Ute (Genzyme 201011 Managing Director of Genzyme CEE GmbH) |
Managing Director |
Sanofi (Group) [since May 2011] |
Germany |
Stölzle-Feix, Sonja (Nanion 201309 Senior Scientist) |
Researcher (industry) |
Nanion (Group) |
Germany |
Su, Muh-Hwan (Sinopharm 201512 General Manager of SynCore Biotechnology Co Ltd) |
Chief Executive Officer (CEO) |
Sinphar Pharmaceutical (Group) |
Taiwan |
Su, Stanley (B Braun 201807 Managing Director Greater China) |
Managing Director |
B. Braun (Group) |
China |
Subkowski, Thomas (BASF 200808) |
n. a. |
BASF (Group) |
Germany |
Subramanian, Romesh (201904 CEO before RaNa Therapeutics + Alexion Pharmaceuticals) |
Chief Executive Officer (CEO) |
Dyne Therapeutics Inc. |
United States (USA) |
Subramanian, Vandana (Sayre Therapeutics 201604 Head of Business Development) |
Business Development Manager / Strategy Manager |
Sayre Therapeutics Pvt. Ltd. |
India |
Suckau, Detlev (Bruker Corp 200803 Bruker Daltonics Head Proteomics RnD) |
Research & Development Manager |
Bruker (Group) |
Germany |
Sudarskis, Alexandre (Neovii Pharmaceuticals AG 201707 CEO before Novartis Vaccines) |
Chief Executive Officer (CEO) |
Neopharm (IL) (Group) |
Switzerland |
Sugo, Tsukasa (GenAhead Bio 201810 CEO) |
Chief Executive Officer (CEO) |
GenAhead Bio Inc. (JP) |
Japan |
Sujka, Sebastian (xbird 202101 CEO + Co-Founder) |
Managing Director |
Glooko (Group) |
Germany |
Sullivan, Elaine (Carrick Therapeutics 201501– CEO before Eli Lilly + Evotec 2015H1– Supervisory Board Member) |
Chief Executive Officer (CEO) |
Carrick Therapeutics (Group) |
Ireland, Republic of |
Sullivan, Patrick J. (Consitution Medical Investors 201307 CEO + Co-founder before Cytyc Corp CEO) |
Chief Executive Officer (CEO) |
Roche (Group) |
United States (USA) |
Sultan, Maha (King Saud Univ 201112 Professor of Analytical Pharm. Chem.) |
Professor |
King Saud University (KSU) |
Saudi Arabia |
Sulzer, Philipp (Ionicon 201108 Science Manager) |
Researcher (industry) |
Ionicon (Group) |
Austria |
Sumeray (formerly Casse), Anna (Virometix 201902– CEO before Alacrita + BioVault + Ariad Europe + Novartis + ADL) |
Managing Partner |
Alacrita (Group) |
Switzerland |
Summerton, Linda (Immodulon Therapeutics 201702 CEO + TranScrip before Merck KGaA + AstraZeneca) |
Chief Executive Officer (CEO) |
|
|
Sumner, Lloyd (Univ Missouri 201806 Prof at UM at Columbia, MO) |
Professor |
University of Missouri System |
United States (USA) |
Sun, Lanny (Full-Life Technologies 202211 CEO before Silicon Therapeutics 202008 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Full-Life Technologies (Group) |
China |
Sundermann, Martin (Osborne Clarke 201612) |
Attorney / Lawyer |
Osborne Clarke (Group) |
Germany |
Sunesson, Lovisa (Invest in Skane 201111 Business Developer) |
Business Development Manager / Strategy Manager |
Skåne (govt region) |
Sweden |
Superti-Furga, Giulio (Austrian Academy of Sciences 201308 Director fo CeMM + Co-Founder of Proxygen) |
President/Director/Head Business Group/Unit/Division |
Austrian Academy of Sciences (ÖAW) |
Austria |
Supper, Jochen (Genomatix Software 201211 Head Computational Biology) |
n. a. |
Genomatix Software (Group) |
Germany |
Surjo, David (CRS 201307 SVP Business Development + Corproate Administration before Pharm PlanNet GmbH) |
Business Development Manager / Strategy Manager |
CRS Clinical Research Services (Group) |
Germany |